Here are four points:
1. Zacks recently lowered EndoChoice from a “hold” rating to a “sell” rating.
2. EndoChoice has a 52-week low of $3.70 and a 52-week high of $19.69.
3. The company has a 50-day moving average price of $5.95 and a 200-day moving average price of $10.47.
4. The firm’s market capitalization is $108.35 million.
More articles on GI/endoscopy:
GI physician to know: Dr. Nicholas Shaheen of UNC Health Care
5 most read GI/endoscopy stories: Week of Feb. 15 — Feb. 19
Dr. Pankaj Vashi: 10 qualities to look for in a GI physician partner
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
